REMINDER: Our focusIR Investor Webinar takes place TONIGHT with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Regulatory News (ZTF)

Share Price Information for Zotefoams (ZTF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 440.00
Bid: 433.00
Ask: 449.00
Change: 0.00 (0.00%)
Spread: 16.00 (3.695%)
Open: 440.00
High: 440.00
Low: 440.00
Prev. Close: 440.00
ZTF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

16 Apr 2019 16:41

RNS Number : 4002W
Zotefoams PLC
16 April 2019
 

Zotefoams plc

(the 'Company')

 

NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PDMRs

 

On 15 April 2019, the Company received notice from its Employee Benefit Trust of the exercise and partial sale for tax of nil cost options granted over ordinary shares of 5 pence each ('Shares') under the Company's 2012 Deferred Bonus Share Plan ('DBSP') and 2007 Long-Term Incentive Plan ('LTIP') by Mr D B Stirling and Mr G C McGrath as follows:

 

Director

 

LTIP

DBSP

Sold for tax

Sale price (£)

Anticipated still to be sold for tax

Balance of shares retained and transferred to Director

D B Stirling

78,203

8,688

8,031

£5.9659

32,808

46,052

G C McGrath

50,828

Nil

4,698

£5.9659

19,191

26,939

 

The shares in the "Anticipated still to be sold for tax" column are those that the Company has been notified are still to be sold for the purpose of satisfying the tax liability generated by the exercise of the options, but which have not been sold as at 15 April 2019. These shares have not been transferred into the name of the Director.

 

Awards granted under the LTIP vest subject to the satisfaction of performance targets over the three-year performance period. The level of vesting for awards granted in 2016 was 100%, which was then increased to reflect the dividends paid during the performance period.

 

Awards granted under the DBSP vest three years from grant, subject to satisfaction of service conditions. The awards were increased to reflect the dividends paid during the restricted period.

 

Following these transactions, which completed on 12 April 2019 and 9 April 2019 (in the case of the transfer of the balance of shares to Mr Stirling), Mr Stirling and Mr McGrath are beneficially interested in the following number of Shares:

 

Director

Number of Shares¹

D B Stirling

492,541

G C McGrath

32,254

 

¹ Includes Partnership Shares, Dividend Shares and vested Matching Shares under the Company's Share Incentive Plan.

 

The Notification of Dealing Form for Mr Stirling and Mr McGrath can be found below.

 

This notification is made in accordance with the Market Abuse Regulation.

 

Enquiries:

James Adams

Interim Company Secretary

Zotefoams plc

 

16 April 2019

 

020 8664 1600

 

About Zotefoams plc:

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology. Using a unique manufacturing process with environmentally friendly nitrogen expansion, Zotefoams produces and sells lightweight AZOTE® polyolefin and ZOTEK® high-performance foams for diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT® advanced insulation for demanding industrial markets. In addition, Zotefoams owns and licenses patented MuCell® microcellular foam technology, developed specifically for extrusion applications, from a base in Massachusetts, USA to customers worldwide.

 

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky and Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA (MuCell Extrusion) and Jiangsu Province, China (T-FIT®).

 

www.zotefoams.com

 

AZOTE®, ZOTEK®, T-FIT® are registered trademarks of Zotefoams plc

MuCell® is a registered trademark of Trexel Inc.

 

 

ZOTEFOAMS PLC

DEALING NOTIFICATION FORMFOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: David Stirling

2.

Reason for the notification

a)

Position/status: Group CEO

b)

Initial notification/Amendment: Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Zotefoams plc

b)

LEI: 213800B6P256B5XN8D32

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 5 pence each

Identification code: GB0009896605

b)

Nature of the transaction: Exercise and retention under the Long-Term Incentive Plan

c)

Price(s) and volume(s):

Price(s)

Volume(s)

£0.00

41,447

d)

Aggregated information:

 

Aggregate Price

Aggregate Volume

Aggregate Total

£0.00

41,447

£0.00

e)

Date of the transaction: 9 April 2019

f)

Place of the transaction: XLON

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 5 pence each

Identification code: GB0009896605

b)

Nature of the transaction: Exercise and sale for tax under the Long-Term Incentive Plan

c)

Price(s) and volume(s):

Price(s)

Volume(s)

£5.9659

7,228

d)

Aggregated information:

 

Aggregate Price

Aggregate Volume

£43,121.53

7,228

e)

Date of the transaction: 12 April 2019

f)

Place of the transaction: XLON

 

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 5 pence each

Identification code: GB0009896605

b)

Nature of the transaction: Exercise and retention under Deferred Bonus Share Plan

c)

Price(s) and volume(s):

Price(s)

Volume(s)

£0.00

4,605

d)

Aggregated information:

 

Aggregate Price

Aggregate Volume

£0.00

4,605

e)

Date of the transaction: 9 April 2019

f)

Place of the transaction: XLON

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 5 pence each

Identification code: GB0009896605

b)

Nature of the transaction: Exercise and sale for tax under Deferred Bonus Share Plan

c)

Price(s) and volume(s):

Price(s)

Volume(s)

£5.9659

803

d)

Aggregated information:

 

Aggregate Price

Aggregate Volume

£4,790.62

803

e)

Date of the transaction: 12 April 2019

f)

Place of the transaction: XLON

 

 

 

 

ZOTEFOAMS PLC

DEALING NOTIFICATION FORMFOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Gary McGrath

2.

Reason for the notification

a)

Position/status: Group CFO

b)

Initial notification/Amendment: Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Zotefoams plc

b)

LEI: 213800B6P256B5XN8D32

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 5 pence each

Identification code: GB0009896605

b)

Nature of the transaction: Exercise and retention under the Long-Term Incentive Plan

c)

Price(s) and volume(s):

Price(s)

Volume(s)

£0.00

26,939

d)

Aggregated information:

 

Aggregate Price

Aggregate Volume

Aggregate Total

£0.00

26,939

£0.00

e)

Date of the transaction: 12 April 2019

f)

Place of the transaction: XLON

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 5 pence each

Identification code: GB0009896605

b)

Nature of the transaction: Exercise and sale for tax under the Long-Term Incentive Plan

c)

Price(s) and volume(s):

Price(s)

Volume(s)

£5.9659

4,698

d)

Aggregated information:

 

Aggregate Price

Aggregate Volume

£28,027.80

4,698

e)

Date of the transaction: 12 April 2019

f)

Place of the transaction: XLON

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHEASLKFDNNEFF
Date   Source Headline
5th Jul 20117:00 amRNSTrading Update
16th Jun 20117:00 amRNSDirectorate Appointments
7th Jun 20119:13 amRNSAnnual Information Update
13th May 20112:10 pmRNSHolding(s) in Company
13th May 201110:34 amRNSResult of AGM
12th May 20117:00 amRNSAGM Statement
3rd May 201112:54 pmRNSTotal Voting Rights
13th Apr 20115:01 pmRNSNotice of AGM
4th Apr 201111:04 amRNSDirector/PDMR Shareholding
31st Mar 20113:04 pmRNSDirector/PDMR Shareholding
31st Mar 20117:00 amRNSAcquisition of MuCell and Share Placing
23rd Mar 20113:24 pmRNSDirector/PDMR Shareholding
8th Mar 20117:00 amRNSFinal Results
14th Feb 20113:47 pmRNSHolding(s) in Company
4th Jan 20113:00 pmRNSHolding(s) in Company
22nd Dec 20103:49 pmRNSHolding(s) in Company
21st Dec 20107:00 amRNSTrading Statement
16th Dec 201012:11 pmRNSHolding(s) in Company
2nd Dec 20109:32 amRNSDirectorate Change
17th Nov 20103:55 pmRNSHolding(s) in Company
17th Nov 20103:52 pmRNSHolding(s) in Company
12th Nov 20103:05 pmRNSDirector/PDMR Shareholding
22nd Oct 20107:00 amRNSInterim Management Statement
22nd Oct 20107:00 amRNSInterim Management Statement
12th Oct 20108:14 amRNSHolding(s) in Company
28th Sep 20105:41 pmRNSHolding(s) in Company
28th Sep 20105:39 pmRNSHolding(s) in Company
28th Sep 20101:00 pmRNSHolding(s) in Company
27th Sep 20103:02 pmRNSHolding(s) in Company
11th Aug 201010:57 amRNSHolding(s) in Company
9th Aug 20103:27 pmRNSHolding(s) in Company
3rd Aug 20107:00 amRNSHalf Yearly Report
1st Jul 20107:00 amRNSTrading Statement
9th Jun 201012:24 pmRNSHolding in company - amendment
9th Jun 201010:32 amRNSHolding(s) in Company
28th May 20103:31 pmRNSAnnual Information Update
17th May 20107:00 amRNSDirector/PDMR Shareholding
13th May 20103:00 pmRNSResult of AGM
11th May 20107:00 amRNSAGM Statement
7th May 20104:06 pmRNSDirector/PDMR Shareholding
12th Apr 20107:00 amRNSNotice of AGM
7th Apr 20104:30 pmRNSDirector/PDMR Shareholding
29th Mar 20108:50 amRNSHolding(s) in Company
24th Mar 201012:46 pmRNSHolding(s) in Company
23rd Mar 20102:40 pmRNSDirector/PDMR Shareholding
15th Mar 20104:52 pmRNSDirector/PDMR Shareholding
9th Mar 20107:00 amRNSFinal Results
3rd Mar 20102:36 pmRNSHolding(s) in Company
10th Dec 20092:30 pmRNSTrading Statement
23rd Oct 20097:00 amRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.